News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Friday, March 06, 2026The European Commissions Health Package introduces the EU Biotech Act and accelerates clinical trial procedures to enhance Europes life sciences competitiveness
EU Health Package Advances Biotech Reforms and Streamlines Clinical Trials for 2026
Thursday, March 05, 2026The European Commission has introduced a comprehensive Health Package including the first phase of the EU Biotech Act and amendments to clinical trials regulation to boost competitiveness and resilience in life sciences
Vericel Receives FDA Approval for Advanced Therapy Manufacturing Plant
Thursday, March 05, 2026Vericel Corporation has received approval from the US Food and Drug Administration to begin commercial manufacturing of MACI at its advanced cell therapy manufacturing plant in Burlington Massachusetts
Antengene and UCB Sign Global Licence Agreement for ATG-201 in Autoimmune Diseases
Wednesday, March 04, 2026Antengene Corporation Limited and UCB have entered into a global licence agreement for ATG a CDCD bispecific Tcell engager TCE for autoimmune diseases
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Tuesday, March 03, 2026The EU Parliament has advanced the Critical Medicines Act to enhance pharmaceutical supply chain security and resilience across Europe starting in
Novo Nordisk to Invest Over €400 Million in Athlone Manufacturing Plant Expansion
Tuesday, March 03, 2026Novo Nordisk has announced an investment of million approximately DKK billion to expand its manufacturing plant in Monksland Athlone Ireland The site produces tabletbased medicines and the upgrade will increase capacity for current and future GLP t...
Sanofi’s Rilzabrutinib Granted Orphan Drug Status in Japan for IgG4-Related Disease
Tuesday, March 03, 2026Sanofi has received orphan drug designation in Japan for rilzabrutinib for the treatment of IgGrelated disease IgGRD The designation was granted by Japans Ministry of Health Labour and Welfare for medicines intended to treat rare conditions with high...
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Monday, March 02, 2026The EU Parliament has advanced the Critical Medicines Act to strengthen Europes pharmaceutical supply chain security and resilience starting in
Neurogene announces FDA Breakthrough Therapy designation for NGN-401 in Rett syndrome
Friday, February 27, 2026Neurogene Inc has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to NGN its investigational gene therapy for Rett syndrome
EU Parliament Advances Critical Medicines Act to Bolster Europe's Medicine Supply Security in 2026
Friday, February 27, 2026The EU Parliament has advanced the Critical Medicines Act aimed at strengthening Europes pharmaceutical supply chain security starting in
